Ferraz-Amaro, Iván http://orcid.org/0000-0003-0197-5267
Corrales, Alfonso
Quevedo-Abeledo, Juan Carlos
Vegas-Revenga, Nuria
Blanco, Ricardo
Portilla, Virginia
Atienza-Mateo, Belén
González-Gay, Miguel Á.
Funding for this research was provided by:
Instituto de Salud Carlos III (PI18/00043)
Article History
Received: 10 December 2020
Accepted: 21 May 2021
First Online: 4 June 2021
Declarations
:
: The study protocol was approved by the institutional review committees at Hospital Universitario de Canarias, Hospital Universitario Doctor Negrín, and Hospital Universitario Marqués de Valdecilla (all in Spain), and all subjects provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests. Nevertheless, Dr. Iván Ferraz-Amaro would like to acknowledge that he has received grants/research supports from Abbott, MSD, Jansen, and Roche, as well as consultation fees from company-sponsored speakers’ bureaus associated with Abbott, Pfizer, Roche, Sanofi, Celgene, and MSD. Prof. M.A. González-Gay has received grants/research supports from AbbVie, MSD, Jansen, and Roche, as well as consultation fees/participation from company-sponsored speakers bureaus organized by AbbVie, Pfizer, Roche, Sanofi, Lilly, Celgene, Sobi, Amgen, and MSD.